Literature DB >> 12948024

Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries.

Imelda Lambkin1, Clemencia Pinilla, Christa Hamashin, Lisa Spindler, Shannon Russell, Amy Schink, Rosa Moya-Castro, Gina Allicotti, Lisa Higgins, Melanie Smith, Jackie Dee, Carolyn Wilson, Richard Houghten, Daniel O'Mahony.   

Abstract

PURPOSE: Various lectins bind specifically to oligosaccharides on intestinal cells. Exploiting this specificity, Ulex europaeus agglutinin I (UEA1) has been used as a ligand for targeted oral vaccine delivery to M cells (antigen-presenting cells) in follicle-associated epithelium. In this study we characterized compounds identified from mixture-based positional scanning synthetic combinatorial libraries, which mimic UEA1 and, thus, may have properties applicable to targeted drug delivery.
METHODS: Two UEA1 mimetics were synthesized and their activity was verified on live cells. The ability of the lead compound, a tetragalloyl D-Lysine amide construct (4-copy gallic acid construct), to deliver dye-loaded polystyrene particles to M cells was assessed in an in situ mouse gut loop model.
RESULTS: The 4-copy gallic acid construct inhibited UEA1 binding to Caco-2 cell membranes with an IC50 of 3 microM, a 650- to 5000-fold increase over the natural UEA1 substrate alpha-L-fucose. The biotin-labeled derivative of this construct demonstrated comparable binding activity as verified on live cells by fluorescence-activated cell sorting. Preclinical studies confirmed its ability to mediate M cell-specific delivery of streptavidin-coated particles in vivo.
CONCLUSIONS: Polyphenolic compounds, D-Lysine scaffolds with multiple galloyl groups, can mimic functional activities of UEA1. Properties of such molecules, including low molecular weight, stability, ease of synthesis and low cost, highlight their potential for application in targeted vaccine delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948024     DOI: 10.1023/a:1025061317400

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

Review 1.  Mixture-based synthetic combinatorial libraries.

Authors:  R A Houghten; C Pinilla; J R Appel; S E Blondelle; C T Dooley; J Eichler; A Nefzi; J M Ostresh
Journal:  J Med Chem       Date:  1999-09-23       Impact factor: 7.446

2.  Drug discovery and vaccine development using mixture-based synthetic combinatorial libraries.

Authors: 
Journal:  Drug Discov Today       Date:  2000-07       Impact factor: 7.851

3.  Intestinal absorption screening of mixtures from combinatorial libraries in the Caco-2 model.

Authors:  E W Taylor; J A Gibbons; R A Braeckman
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

4.  Targeting to intestinal M cells.

Authors:  M A Jepson; M A Clark; N Foster; C M Mason; M K Bennett; N L Simmons; B H Hirst
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

5.  Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures.

Authors:  C L Stevenson; P F Augustijns; R W Hendren
Journal:  Int J Pharm       Date:  1999-01-15       Impact factor: 5.875

Review 6.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.

Authors:  Mathai Mammen; Seok-Ki Choi; George M Whitesides
Journal:  Angew Chem Int Ed Engl       Date:  1998-11-02       Impact factor: 15.336

7.  Role of ABH blood group antigens in the stimulation of a DIDS-sensitive Ca2+ influx pathway in human erythrocytes by Ulex europaeus agglutinin I and a monoclonal anti A1 antibody.

Authors:  B Engelmann; U Schumacher; J Duhm
Journal:  Biochim Biophys Acta       Date:  1991-02-19

8.  Mode of molecular recognition of L-fucose by fucose-binding legume lectins.

Authors:  C J Thomas; A Surolia
Journal:  Biochem Biophys Res Commun       Date:  2000-02-16       Impact factor: 3.575

9.  Differential expression of lectin-binding sites defines mouse intestinal M-cells.

Authors:  M A Clark; M A Jepson; N L Simmons; T A Booth; B H Hirst
Journal:  J Histochem Cytochem       Date:  1993-11       Impact factor: 2.479

10.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

View more
  8 in total

Review 1.  Drug delivery to the small intestine.

Authors:  David R Friend
Journal:  Curr Gastroenterol Rep       Date:  2004-10

Review 2.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

3.  Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus.

Authors:  Karen Misstear; Edel A McNeela; Alison G Murphy; Joan A Geoghegan; Kate M O'Keeffe; John Fox; Kin Chan; Simon Heuking; Nicolas Collin; Timothy J Foster; Rachel M McLoughlin; Ed C Lavelle
Journal:  J Infect Dis       Date:  2013-11-22       Impact factor: 5.226

4.  In vivo phage display to identify M cell-targeting ligands.

Authors:  Lisa M Higgins; Imelda Lambkin; Graham Donnelly; Daragh Byrne; Carolyn Wilson; Jacqueline Dee; Melanie Smith; Daniel J O'Mahony
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.580

Review 5.  Needle-Free Immunization with Chitosan-Based Systems.

Authors:  Bijay Singh; Sushila Maharjan; Princy Sindurakar; Ki-Hyun Cho; Yun-Jaie Choi; Chong-Su Cho
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

Review 6.  Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization.

Authors:  Carlos Gamazo; Nekane Martín-Arbella; Ana Brotons; Ana I Camacho; J M Irache
Journal:  Eur J Pharm Biopharm       Date:  2015-01-20       Impact factor: 5.571

Review 7.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02

Review 8.  An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery.

Authors:  Kailash C Petkar; Suyash M Patil; Sandip S Chavhan; Kan Kaneko; Krutika K Sawant; Nitesh K Kunda; Imran Y Saleem
Journal:  Pharmaceutics       Date:  2021-03-27       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.